London
· Delayed Price · Currency is GBP · Price in EUR ABIVAX Société Anonyme Statistics
Total Valuation
ABIVAX Société Anonyme has a market cap or net worth of GBP 332.18 million. The enterprise value is 240.04 million.
| Market Cap | 332.18M |
| Enterprise Value | 240.04M |
Important Dates
The next estimated earnings date is Friday, March 14, 2025.
| Earnings Date | Mar 14, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | n/a |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +97.36% |
| Shares Change (QoQ) | +25.27% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 30.06M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | n/a |
| P/TBV Ratio | 3.86 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -1.60 |
| EV / Sales | 31.43 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -1.83 |
Financial Position
The company has a current ratio of 3.04, with a Debt / Equity ratio of 0.90.
| Current Ratio | 3.04 |
| Quick Ratio | 2.98 |
| Debt / Equity | 0.90 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.73 |
| Interest Coverage | -15.83 |
Financial Efficiency
Return on equity (ROE) is -171.46% and return on invested capital (ROIC) is -57.12%.
| Return on Equity (ROE) | -171.46% |
| Return on Assets (ROA) | -46.69% |
| Return on Capital (ROIC) | -57.12% |
| Revenue Per Employee | 123,494 |
| Profits Per Employee | -2.43M |
| Employee Count | 61 |
| Asset Turnover | 0.04 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -39.96% in the last 52 weeks. The beta is 1.42, so ABIVAX Société Anonyme's price volatility has been higher than the market average.
| Beta (5Y) | 1.42 |
| 52-Week Price Change | -39.96% |
| 50-Day Moving Average | 7.80 |
| 200-Day Moving Average | 11.07 |
| Relative Strength Index (RSI) | 35.74 |
| Average Volume (20 Days) | 1,169 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, ABIVAX Société Anonyme had revenue of GBP 7.66 million and -150.42 million in losses. Loss per share was -2.66.
| Revenue | 7.66M |
| Gross Profit | 7.66M |
| Operating Income | -144.28M |
| Pretax Income | -150.42M |
| Net Income | -150.42M |
| EBITDA | -144.02M |
| EBIT | -144.28M |
| Loss Per Share | -2.66 |
Balance Sheet
The company has 188.48 million in cash and 96.11 million in debt, giving a net cash position of 92.37 million.
| Cash & Cash Equivalents | 188.48M |
| Total Debt | 96.11M |
| Net Cash | 92.37M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 107.22M |
| Book Value Per Share | 1.70 |
| Working Capital | 138.21M |
Cash Flow
In the last 12 months, operating cash flow was -131.16 million and capital expenditures -299,280, giving a free cash flow of -131.46 million.
| Operating Cash Flow | -131.16M |
| Capital Expenditures | -299,280 |
| Free Cash Flow | -131.46M |
| FCF Per Share | n/a |
Margins
| Gross Margin | 100.00% |
| Operating Margin | -1,884.32% |
| Pretax Margin | -1,964.62% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
ABIVAX Société Anonyme does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -97.36% |
| Shareholder Yield | -97.36% |
| Earnings Yield | -45.28% |
| FCF Yield | -39.58% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
ABIVAX Société Anonyme has an Altman Z-Score of -0.27. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -0.27 |
| Piotroski F-Score | n/a |